Newsmeme!
Discover News you didn't know existed
Treatment of prostate cancer using a very low dose of nitroglycerin may slow and even halt the progression of the disease without the severe side effects of current treatments, Queen's University researchers have discovered The findings are the result of the first-ever clinical trial using nitroglycerin to treat prostate cancer. The 24-month, Phase II study targeted 29 men with increasing levels ...
He's clever, sexy and a doctor to boot. Dr Shingai Mutambirwa is one of 702 Talk Radio's darlings and has just added us to his list of admirers, writes Helen Grange.
WEST CALDWELL TWP. –Resident Rob Hunter has published a book on a topic he says all couples with children eventually face. The title is “Real Men Get Snipped! The Ultimate Vasectomy Guide for Couples.”
I graduated from medical school more years ago than I care to admit, and looking at medical technology now, all I can think is, "We've come a long way, baby!" The phrase popped to mind again recently when I learned about the new SSM Robotic Surgery Institute at DePaul Health Center.
Title: Medicare Cost-Saving Moves Can Backfire Category: Health News Created: 2/9/2010 8:10:00 AM Last Editorial Review: 2/9/2010
UTICA, February 9, 2010 -- Richard I. Silver, MD, FACS, FAAP, has joined Mohawk Valley Urology, PC to practice with Dr. Jonathan Block and Dr. Ronald Kaye at 1703 Genesee Street, Utica.
Treatment of prostate cancer using a very low dose of nitroglycerin may slow and even halt the progression of the disease without the severe side effects of current treatments, Queen's University researchers have discovered
Treatment of prostate cancer using a very low dose of nitroglycerin may slow and even halt the progression of the disease without the severe side effects of current treatments, Queen's University researchers have discoveredThe findings are the result of the first-ever clinical trial using nitroglycerin to treat prostate cancer.The 24-month, Phase II study targeted 29 men with increasing levels ...
HASBROUCK HEIGHTS, N.J. -- Nymox Pharmaceutical Corporation provided an update today on the Company's Phase 3 program for NX-1207, Nymox's investigational drug for benign prostatic hyperplasia .
Upping payments for bladder biopsies done in doctor's office boosted overall spending, study found.
Related News Resources:
> HGH News
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |